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Abstract
Background: There is a need for a large, contemporary, multi-centre series of measured glomerular filtration rates
(mGFR) from healthy individuals to determine age- and gender-specific reference ranges for GFR. We aimed to
address this and to use the ranges to provide age- and gender-specific advisory GFR thresholds considered
acceptable for living kidney donation.
Methods: Individual-level data including pre-donation mGFR from 2974 prospective living kidney donors from 18
UK renal centres performed between 2003 and 2015 were amalgamated. Age- and gender-specific GFR reference
ranges were determined by segmented multiple linear regression and presented as means ± two standard
deviations.
Results: Males had a higher GFR than females (92.0 vs 88.1 mL/min/1.73m2, P < 0.0001). Mean mGFR was
100 mL/min/1.73m2 until 35 years of age, following which there was a linear decline that was faster in
females compared to males (7.7 vs 6.6 mL/min/1.73m2/decade, P = 0.013); 10.5% of individuals aged > 60 years had a
GFR < 60 mL/min/1.73m2. The GFR ranges were used along with other published evidence to provide
advisory age- and gender-specific GFR thresholds for living kidney donation.
Conclusions: These data suggest that GFR declines after 35 years of age, and the decline is faster in females.
A significant proportion of the healthy population over 60 years of age have a GFR < 60 mL/min/1.73m2
which may have implications for the definition of chronic kidney disease. Age and gender differences in
normal GFR can be used to determine advisory GFR thresholds for living kidney donation.
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Background
The glomerular filtration rate (GFR) is a standard meas-
ure of renal function and can be determined by measur-
ing the clearance of a molecule freely filtered through
the glomerulus (measured GFR, mGFR). Although urin-
ary inulin clearance is the gold standard method for
determining mGFR, measuring the plasma clearance of
51Cr-EDTA is less cumbersome to perform and provides
comparatively accurate results [1]. It is, therefore, the
method used most commonly in the UK and throughout
Europe, and is the technique recommended by the
British Nuclear Medicine Society (BNMS) [2].
It is important to have accurate reference ranges for
GFR. The current BNMS guideline quotes a reference
range based on a series of mGFRs in 503 healthy subjects
published in 1981: mean GFR in young adults was
105 mL/min/1.73m2 which declined by 4 mL/min/
1.73 m2 per decade up to 50 years of age, and 10 mL/min/
1.73m2 per decade thereafter [2, 3]. Similarly, in the
largest study to date of mGFRs in a healthy population,
which included 1057 prospective living kidney donors,
mGFR declined by 4mL/min/1.73 m2 per decade up to
the age of 45 years, and 8mL/min/1.73m2 per decade
thereafter [4]. A single-centre cohort of 904 prospective
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living kidney donors found the decline in mGFR with age
was nonlinear, getting steeper with age [5]. Several studies
have also reported gender to be a determinant of GFR [4,
6, 7]. It is important therefore that GFR reference ranges
account for age and gender.
The purpose of this study was to use a large, contem-
porary, multi-centre series of mGFRs from healthy indi-
viduals to determine age- and gender-specific reference
ranges. We also examined whether age and gender are de-
terminants of GFR in a subgroup of individuals selected
on the basis of having no evidence of kidney pathology.
Further, we describe how our GFR reference ranges can
be used to inform minimum thresholds of GFR considered
safe for prospective living kidney donors to proceed to
nephrectomy. This work formed the basis of new recom-
mendations for the assessment of kidney function in the
updated British Transplantation Society (BTS) guidelines
on living donor kidney transplantation [8].
Methods
This was a retrospective study using routinely-collected
health data. The study population comprised prospect-
ive living kidney donors from UK renal centres who
had undergone mGFR as part of their evaluation and
were included irrespective of whether or not they pro-
ceeded to donation. Prospective donors with significant
co-morbidity are excluded before the stage of having
mGFR and therefore our study population can reasonably
be regarded as representative of the healthy population.
We used hospital databases to identify prospective
kidney donors who had undergone mGFR in three
renal centres: Queen Elizabeth Hospital, Birmingham,
2007–2014; Freeman Hospital, Newcastle upon Tyne,
2009–2015; and James Cook University Hospital, Middles-
brough, 2005–2015. All prospective donors with mGFR
during these years were included, and patient records
were used to extract individual age, gender, and mGFR.
These data from our three centres were then amalgamated
with individual-level data from a published study of
mGFRs in prospective living kidney donors from 15 other
UK renal centres [9] (measured between 2003 and 2010,
although the years of measurement varied between cen-
tres, and completeness of capture for each centre is not
known), producing a dataset of prospective donors
from 18 centres with the following variables: age, sex,
renal centre, and mGFR per 1.73 m2 body surface
area (BSA).
GFR measurement
All 18 centres adhered to the BNMS guidelines for the
measurement of GFR [2]. mGFR was determined by
measuring the plasma clearance of a glomerular filtra-
tion tracer using the slope-intercept method with the
Brochner-Mortensen correction applied [10]. The tracer
used was 51Cr-EDTA in our three centres and in all of the
other 15 centres apart from one which used 99mTc-DTPA.
The number of plasma samples obtained to calculate
mGFR was two in our centres and varied between two to
five in the 15 other centres. The Haycock formula, incorp-
orating height and weight, was used to estimate BSA, and
mGFR was scaled to 1.73m2 BSA [11].
Statistical methods
Continuous variables are expressed as a mean and stand-
ard deviation. Reference ranges for GFR were created
using segmented multiple linear regression incorporating
the amalgamated data from all 18 centres to model mGFR
as a function of age and gender. A normal probability plot
was used to confirm the validity of the assumption that
the residuals were from a Normal distribution. The upper
and lower limits of the reference ranges were defined as
two standard deviations (SD) above and below the mean,
respectively. These ranges, in addition to other published
evidence as described below, were used to establish GFR
thresholds for prospective living kidney donors, below
which kidney donation would not be recommended.
Subgroup analysis
We identified a subgroup of prospective kidney donors
from our three centres who had no proteinuria, normal
renal imaging, and normal differential kidney function
by collecting the following additional data from individ-
ual patient records: urine albumin-to-creatinine ratio
(ACR) or protein-to-creatinine ratio (PCR), renal CT or
MR imaging report, and differential kidney function by
DMSA.
Prospective donors with any evidence of kidney path-
ology were excluded. Evidence of kidney pathology was
defined as proteinuria (ACR ≥ 2.5 mg/mmol in males
or ≥ 3.5 mg/mmol in females, or PCR ≥ 20 mg/mmol),
abnormal renal imaging (other than angiomyolipoma, a
few simple cysts, or a duplex system), or a > 10% differ-
ence in differential kidney function on DMSA. Those
with missing data in any of these three variables were
also excluded.
Data from the resultant subgroup of prospective living
kidney donors with no evidence of kidney pathology
were used to model mGFR as a function of age and gen-
der as above.
Results
Study population and GFR reference ranges
We identified and collected data for 1096 prospective
living kidney donors from our three centres who had
undergone mGFR between 2007 and 2015. These data
were amalgamated with individual-level data from 1878
prospective donors from the 15 other UK renal centres,
producing a dataset for 2974 prospective donors from
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18 centres. 1284 (43.2%) were male, mean age was
46.3 years (SD 12.3), and mean mGFR was 89.8 mL/
min/1.73m2 (SD 15.8). The cohort included 459 (15.4%)
individuals over 60 years of age, 51 (1.7%) individuals
over 70 years, and 1 (0.0%) individual over the age of
80 years. Figure 1 shows a scatter plot of mGFR by age.
Overall, 78 (2.6%) individuals had a mGFR < 60 mL/
min/1.73m2. Forty-eight (10.5%) of the 459 individuals
aged over 60 years had a mGFR < 60 mL/min/1.73m2.
The means and reference ranges for GFR by age and
gender are shown in Table 1 and Fig. 2. Overall males
had a higher mGFR than females (92.0 vs 88.1 mL/min/
1.73m2, P < 0.0001). Measured GFR was approximately
100 mL/min/1.73m2 until 35 years of age, following
which there was a linear decline. This GFR decline was
faster in females compared to males (7.7 vs 6.6 mL/min/
1.73 m2/decade, P = 0.013). BSA did not correlate with
age for males or females.
Subgroup of prospective donors with no evidence of
kidney pathology
Of the 1096 prospective donors in our three centres, 220
(20.1%) were excluded as they had missing data in one
or more of the three following variables: ACR or PCR,
renal imaging report, or DMSA result. Of the remaining
876 individuals with a complete dataset, 155 (17.7%)
were excluded as they had evidence of renal pathology:
82 (9.4%) had a > 10% difference in differential kidney
function on DMSA, 67 (7.6%) had abnormal renal
imaging, and 25 (2.9%) had proteinuria (these total 174
because 19 of the 155 excluded individuals had two ab-
normal variables). Therefore, 721 prospective donors
from our three centres were included in the subgroup
analysis and their baseline characteristics are presented
in Additional file 1: Table S1. Mean age was 45.7 (SD
12.5) years and 323 (44.8%) were male. Mean mGFR in
the subgroup was significantly higher compared to those
excluded from our three centres (91.6 ± 14.4 vs 85.6 ±
14.0 mL/min/1.73m2, P < 0.001). As in the total cohort
of prospective donors, mGFR in the subgroup declined
with age and the GFR decline after 35 years of age was
more rapid in females. In addition, males had a higher
initial mGFR which showed a continuous linear decline,
unlike females who had a lower initial mGFR that was
stable until 35 years of age before a linear decline. Mean
GFR ± two SDs for the subgroup are shown in Additional
file 1: Table S2 and Figure S1.
Thresholds for living kidney donation
Age- and gender-specific mGFR thresholds, considered
acceptable for prospective living kidney donors to
proceed to nephrectomy, are shown in Table 2 and
Additional file 1: Figure S2. We set a threshold mGFR
of > 90 mL/min/1.73m2 for prospective donors younger
than 30 years and a threshold of > 80 mL/min/1.73m2
for those aged 30–45 years. For those older than 45 years,
Fig. 1 Scatter plot of measured GFR by age in 2974 prospective living kidney donors. GFR, glomerular filtration rate
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the mGFR threshold was determined by calculating the
lowest pre-donation mGFR that would leave the donor
with a post-donation GFR within the reference range for
their age and gender, assuming a 25% loss of GFR with
donation. The rationale for these thresholds, which were
determined based on our age- and gender-specific GFR
reference ranges and previously published evidence, is
discussed below.
Discussion
This study is to the best of our knowledge the largest pub-
lished series to date of mGFRs in a healthy population,
and we have used it as the basis for new age- and
gender-specific reference ranges for GFR and to define ad-
visory mGFR thresholds for living kidney donation that
form part of the updated BTS guidelines [8]. In 2974 pro-
spective living kidney donors from 18 UK centres, we
found that young adults had an mGFR of approximately
100 mL/min/1.73m2 until 35 years of age, following which
there was a linear decline that was faster in females. An
age-related decline in GFR, which was faster in females,
was confirmed in a subgroup of prospective donors se-
lected on the basis of no proteinuria, normal renal im-
aging, and normal differential kidney function.
Ageing and GFR
Our finding that GFR is approximately 100 mL/min/
1.73m2 in young adults is consistent with previously
published data [3, 5, 12]. Published studies consistently
show that GFR declines with age in healthy individuals,
and it has been demonstrated that ageing is also associ-
ated with a decline in other physiological parameters,
such as renal blood flow, and with structural changes
such as a reduction in nephron number, glomerulo-
sclerosis, and tubulointerstitial fibrosis [13–15].
Over 10% of prospective donors older than 60 years had
a mGFR < 60 mL/min/1.73m2, and our model suggests
that the lower limit of the normal range for GFR drops
to 60 mL/min/1.73m2 by the age of 50 and 55 years for
females and males, respectively, meeting the GFR
Table 1 Age- and gender-specific normal GFR reference ranges
based on measured GFRs from 2974 prospective living kidney
donors
Agea Measured GFRb
Male Female
Lower
limit
Mean Upper
limit
Lower
limit
Mean Upper
limit
20–34 74 100 127 72 99 125
35 73 100 126 72 99 125
40 70 96 123 68 95 121
45 67 93 119 64 91 117
50 63 90 116 60 87 114
55 60 86 113 56 83 110
60 57 83 110 52 79 106
65 53 80 106 48 75 102
70 50 77 103 44 71 98
75 47 73 100 40 67 94
80 43 70 97 36 63 90
GFR Glomerular filtration rate
ayears
bmL/min/1.73m2
Fig. 2 Age- and gender-specific GFR reference ranges based on measured GFRs from 2974 prospective living kidney donors. Solid lines represent
mean GFR, and interrupted lines are two standard deviations above and below the mean. GFR, glomerular filtration rate
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cut-off in the current definition of chronic kidney dis-
ease (CKD) [16]. Our age- and gender-specific GFR ref-
erence ranges may be useful in the management of an
older individual with a GFR < 60 mL/min/1.73m2: if
GFR is within their reference range and there is no
other evidence of kidney disease, one may be more
confident in attributing a GFR < 60 mL/min/1.73m2 to
normal ageing rather than disease, which may help to
avoid unnecessary investigation and over-medicalisation.
A meta-analysis which evaluated the interaction of age on
the association between creatinine-based eGFR and
end-stage renal disease (ESRD) and mortality suggested
that a low eGFR is associated with increased risks across
all age groups, although the relative mortality risk as-
sociated with a reduced eGFR decreased with increas-
ing age [17].
It should also be noted that men younger than 55 years
and women younger than 50 years could have a GFR
below the lower limit of their reference range but still
≥60 mL/min/1.73m2 and so, in the absence of another
marker of renal disease, would be missed by the current
definition of CKD. The available data on long-term out-
comes is insufficient to know whether a young individual
in this category is at an increased lifetime risk of adverse
health outcomes.
The definition and diagnosis of CKD, particularly in
the older population, is an area of ongoing debate, and a
discourse on the use of a single GFR cut-off is beyond
the scope of this paper. However, several reviews and
opinion pieces have suggested that greater emphasis
should be placed on age-related changes in GFR than
current definitions of CKD allow for [12, 18, 19]. Our
data showing that over 10% of healthy adults over
60 years of age have a GFR < 60 mL/min/1.73m2 could
be used to support that position.
Gender and GFR
Although most studies have found no significant differ-
ence in GFR between males and females, our findings that
males have a higher overall GFR and a less rapid decline
with age are consistent with the results of several other
reports [6, 20–22]. These findings were also evident in the
subgroup of prospective donors with no evidence of kid-
ney pathology.
Several theories have been proposed to explain the
more rapid GFR decline seen in females. First, it has
been proposed that females may have a higher GFR than
males in young adulthood that is masked by scaling to
BSA, which may lead to a faster rate of GFR decline
similar to that seen in hyperfiltration-related renal path-
ology [9]. Second, as females age, the impact of oestro-
gens on renal haemodynamics and structure are lost due
to a gradual decline in oestrogen levels even before the
menopause [23–25]. There is no evidence that this faster
rate of decline in females is detrimental to health, and in
the UK the prevalence of ESRD in women is actually
lower than in men at all ages [26].
Minimum advisory GFR thresholds for living kidney
donation
The evaluation of prospective living kidney donors aims
to identify those whom donation would put at an un-
acceptably high risk of long-term complications, including
ESRD. Previous studies have suggested that the risk of
ESRD after living kidney donation is not higher than in
the general population [27, 28], but there is a small abso-
lute increased risk [29–31]. A recent meta-analysis found
the relative risk for ESRD was about 9-fold higher in
donors compared to non-donors, but the estimated inci-
dence rate was less than 1 case per 1000 person-years
[32]. Assessment of GFR in prospective kidney donors is
an important factor in determining risk and living kidney
donation guidelines have provided threshold GFRs above
which the increased risk may generally be considered
acceptable. For example, the 2017 KDIGO guideline
suggests that a GFR ≥90 mL/min/1.73m2 is acceptable for
donation, while a GFR < 60 mL/min/1.73m2 is not accept-
able for donation and a GFR 60–89 mL/min/1.73m2 may
be acceptable depending on other risk factors [33].
We recommended an advisory threshold GFR of > 80
mL/min/1.73 m2 for prospective donors aged 30–45,
because this appears safe based on long-term outcome
studies showing only a very small absolute increased
risk of ESRD in cohorts of donors with this level of
renal function and in this age range [30, 31]. However,
because these studies contained only small numbers of
Table 2 Advisory age- and gender-specific threshold GFRs
considered acceptable for living kidney donation
Agea Threshold GFRb
Male Female
20–29 90 90
30–34 80 80
35 80 80
40 80 80
45 80 80
50 80 80
55 80 75
60 76 70
65 71 64
70 67 59
75 63 54
80 58 49
GFR Glomerular filtration rate
ayears
bmL/min/1.73m2
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younger donors, and another study showed an in-
creased absolute lifetime risk in younger donors with a
GFR < 90 mL/min/1.73m2 [34], we have recommended
an advisory threshold GFR of > 90 mL/min/1.73m2 for
donors younger than 30 years of age.
For those over 45 years, we have recommended ad-
visory GFR thresholds based on calculating the lowest
pre-donation GFR that would leave the donor with a
post-donation GFR within our age- and gender-specific
GFR normal ranges, assuming a 25% loss of GFR [27, 35,
36]. Based on data showing that age-related GFR decline
after donation appears to be slower than in the general
population, donors should remain within the healthy ref-
erence range up to the age of 80 years [27, 35, 37]. Whilst
it is acknowledged that these may be considered arbitrary
thresholds, from first principles it would seem sensible to
aim to keep GFR in the normal range. Our thresholds, un-
like those in the KDIGO guideline, would also allow some
older donors with a GFR < 60 mL/min/1.73m2 to donate.
In our study population of 2974 prospective donors,
these GFR thresholds would lead to the exclusion of an
additional 5.0% (19.9% vs 14.8%) of prospective donors
compared to the thresholds in the previous BTS living
kidney donation guidelines if adhered to rigidly [38].
However, whilst threshold GFRs provide useful guid-
ance to clinicians assessing prospective living kidney
donors, individualised decision-making is important,
especially in cases where GFR may be just below the
recommended advisory threshold, or where there are
compounding risk factors for ESRD. This has recently
been facilitated by the development of an online tool
(www.transplantmodels.com/esrdrisk) which provides a
15-year and lifetime pre-donation risk of ESRD in pro-
spective donors, which was based on a meta-analysis of
data from nearly 5 million healthy individuals, similar
to kidney donor candidates, from general population
cohorts [34].
The strengths of this study include the large size of the
cohort and the fact that it incorporates individuals from
multiple centres which increases diversity and the general-
isability of our reference ranges. However, we recognise
that our study has some limitations. First, it is likely that
there is some variation in practice between the 18 centres
in conducting mGFRs. There was variation in the number
of blood samples taken to calculate mGFR, one centre
used a different glomerular filtration tracer, and there may
have been variation in pre-procedure advice given to indi-
viduals, such as that pertaining to diet, medications, and
fasting.
Second, our estimates of GFR in the general population
may be biased by the use of prospective living kidney do-
nors as our study population. Individuals who have volun-
teered to donate a kidney and have had a satisfactory
initial medical assessment to reach the point of having
their GFR measured are likely to be healthier than the
unscreened general population, and we would therefore
anticipate a higher reference range than in the general
population. Conversely, many prospective kidney donors
are related to the intended recipient with renal failure, and
therefore the proportion of individuals in our study popu-
lation with a family history of renal disease is almost cer-
tainly higher than in the general population. This may
have resulted in a lower estimate of GFR than truly exists
in the general population. We did not have data on
donor-recipient relationship to examine this further. An-
other consequence of using prospective kidney donors
was that there were relatively few individuals in the cohort
over 70 years of age, and this is to be borne in mind when
interpreting our GFR reference ranges in this age group.
Third, our data are cross-sectional rather than longitu-
dinal. The change in GFR that we describe with age is
the change in mean GFR at population level and does
not necessarily describe the expected change in an indi-
vidual’s GFR with ageing. Indeed, previous work has
shown that there is considerable variation in GFR de-
cline with age [14, 39].
Finally, we did not have ethnicity data, which would
have allowed us to validate previous work which has
suggested that individuals of Asian ethnicity have a
lower GFR [20, 40, 41]. Whether or not ethnicity is a
determinant of GFR is an important question which
requires further study in large, ethnically diverse co-
horts, with accurate measures of GFR.
A large multi-centre observational cohort study with
prospective recruitment of potential living kidney donors,
incorporating baseline and longitudinal demographic and
bioclinical data with a standardized method for mGFR
and other renal phenotyping would be desirable to provide
robust data on the effects of age, gender, and ethnicity
on GFR.
Conclusions
We have used a large multi-centre series of mGFR data
from prospective living kidney donors to produce age-
and gender-specific GFR reference ranges which have clin-
ical utility during the assessment of potential living kidney
donors and may have implications for the diagnosis of
CKD in the general population.
Additional file
Additional file 1: Table S1. Characteristics of subgroup of prospective
living kidney donors from three centres with no proteinuria, normal renal
imaging, and normal differential kidney function (N = 721). Table S2.
Measured GFR (mean ± 2 SD) by age and gender in a subgroup of
prospective living donors from three centres selected on basis of no
proteinuria, normal renal imaging, and normal differential kidney function
(N = 721). Figure S1. Measured GFR (mean ± 2 SD) by age and gender in
a subgroup of prospective living donors from three centres with no
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proteinuria, normal renal imaging, and normal differential kidney function
(N = 721). Figure S2. Advisory age- and gender-specific threshold GFRs
for prospective living kidney donors to proceed to nephrectomy for
males (A, blue) and females (B, red). (DOCX 258 kb)
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